Pharmaceuticals, Biotechnology and Life Sciences
The new treatment can potentially provide benefits superior to other commontherapies greatly improving clinical outcomes for patients being treatedfor lung cancer.
DUBLIN–(BUSINESS WIRE)–The “Cough – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Cough – Pipeline Review,…
DUBLIN–(BUSINESS WIRE)–The “eClinical Solutions Market Size, Share & Trends Analysis Report By Product (CTMS, ECOA, EDC, CDMS, RTSM, eTMF), By…
DUBLIN–(BUSINESS WIRE)–The “Primary Immune Deficiency (PID) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Primary…
Patent claims RSV fusion protein inhibitors as medicines including lead pipeline candidate, RV521; patent nominally expires in 2035 (unextended) The…
SAN DIEGO–(BUSINESS WIRE)–Turning Point Therapeutics, Inc., a clinical-stage precision oncology company developing novel drugs that address treatment resistance, announced today…
Novel DNA Manufacturing Platform Seeks to Pioneer New Generation of Faster, More Affordable Cell-based Therapeutics for Patients STONY BROOK, N.Y.–(BUSINESS…
COLUMBUS, Ohio–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AI?src=hash" target="_blank"gt;#AIlt;/agt;–Deep Lens, Inc., an AI-driven digital pathology company focused on clinical trial recruitment at the time…
MENLO PARK, Calif.–(BUSINESS WIRE)–Avellino Labs, global biotechnology and genetic science innovators, announced the strategic addition of James (Jim) V. Mazzo…
QUEBEC–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation focused on developing…